Table 4.
AAS use side effects among users.
| Overall | Women | Men | |
|---|---|---|---|
| % | % | % | |
| Abnormal lipids and/or cholesterol levels | 27.3 | 16.7 | 27.8 |
| Acne | 34.1 | 50.0 | 30.6 |
| Clitoral enlargement | 2.3 | 0.0 | 0.0 |
| Edema | 11.4 | 0.0 | 13.9 |
| Gynecomastia | 9.1 | 0.0 | 11.1 |
| Hair loss | 20.5 | 16.7 | 22.2 |
| Heart palpitations or racing heart | 13.6 | 16.7 | 13.9 |
| Increased blood pressure | 27.3 | 16.7 | 30.6 |
| Injection site pain | 18.2 | 0.0 | 22.2 |
| Insomnia or trouble falling or staying asleep | 29.6 | 33.3 | 30.6 |
| Irregular menstrual cycle | 4.6 | 2.0 | 0.0 |
| Mood changes | 34.1 | 33.3 | 33.3 |
| Sexual dysfunction | 13.6 | 16.7 | 13.9 |
| Striae | 18.2 | 16.7 | 19.4 |
| Testicular atrophy | 20.5 | 0.0 | 25.0 |
| Voice changes | 9.1 | 0.0 | 8.3 |
| Other side effects | 11.4 | 0.0 | 11.1 |
| No side effects | 25.0 | 33.3 | 22.2 |
Note. Given small cell size, stratified analyses were not conducted among transgender/gender non-conforming participants.
AAS = Anabolic-androgenic steroids